$107.170
-5.101 (-4.76%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
RYTM Prediction & Forecast by Similar Chart Analysis
Alphio's RYTM stock price prediction model matches the current Rhythm Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $109.21 (+1.90%). The 1-week path is $110.47 (+3.08%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Rhythm Pharmaceuticals Inc Stock?
Rhythm Pharmaceuticals Inc is currently a hold. The current price is $107.17, with a gross margin of 26.52% reported for Q2 2026, which is significantly lower than previous quarters. The forward P/E ratio is not applicable, indicating potential volatility. However, the recent approval of IMCIVREE in Japan could drive future growth, as it opens up a new market for the company. The main risk is the declining gross margin, which has dropped from over 90% in previous quarters to 26.52% in the latest report, indicating potential challenges in maintaining profitability.
RYTM stock price ended at $107.17 on Friday, after losing -4.76%
Rhythm Pharmaceuticals Inc (RYTM) last closed at $107.17, losing -4.76%. These facts feed the 1-day and 1-week RYTM price prediction above.
Analyst Consensus
Rhythm Pharmaceuticals Inc (RYTM): 3 buy, 1 hold, 0 sell. Outlook: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Rhythm Pharmaceuticals Inc (RYTM) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches RYTM, ranked by similarity.
Seasonality analysis for RYTM
Historically the probability of a positive August return for RYTM is 88.89%. September offers the highest probability of a positive month at 100.00%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for RYTM
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $80.25 | $85.57 | $98.99 | -20.16% |
| Sep 2026 | $76.89 | $89.65 | $105.59 | -16.35% |
| Oct 2026 | $78.63 | $89.06 | $92.65 | -16.90% |
| Nov 2026 | $80.59 | $81.63 | $82.68 | -23.83% |
| Dec 2026 | $61.13 | $76.83 | $80.41 | -28.31% |
In 2026, Rhythm Pharmaceuticals Inc (RYTM) is projected to range from $61.13 to $105.59.
Rhythm Pharmaceuticals Inc 2026 monthly forecast
In Aug 2026, Rhythm Pharmaceuticals Inc is projected to average $85.57, with a low of $80.25 and high of $98.99.
In Sep 2026, Rhythm Pharmaceuticals Inc is projected to average $89.65, with a low of $76.89 and high of $105.59.
In Oct 2026, Rhythm Pharmaceuticals Inc is projected to average $89.06, with a low of $78.63 and high of $92.65.
In Nov 2026, Rhythm Pharmaceuticals Inc is projected to average $81.63, with a low of $80.59 and high of $82.68.
In Dec 2026, Rhythm Pharmaceuticals Inc is projected to average $76.83, with a low of $61.13 and high of $80.41.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.